Article
TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
Antimicrobial agents and chemotherapy - 1 Dec 2004
Poirel Laurent, Mammeri Hedi, Nordmann Patrice
Abstract excerpt
Enterobacter aerogenes clinical isolate LOR was resistant to penicillins and ceftazidime but susceptible to cefuroxime, cephalothin, cefoxitin, cefotaxime, ceftriaxone, and cefepime. PCR and cloning experiments from this strain identified a novel TEM-type beta-lactamase (TEM-121) differing by five amino acid substitutions from beta-lactamase TEM-2 (Glu104Lys, Arg164Ser, Ala237Thr, Glu240Lys, and Arg244Ser) and by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
